Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection

18Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis C virus (HCV) infection is a global medical problem. The current standard of treatment consists of the combination of peginterferon plus ribavirin. This regimen eradicates HCV in 55% of cases. The immune response to HCV is an important determinant of disease evolution and can be influenced by various host factors. HLA class II may play an important role in immune response against HCV. The objective of the present study was to determine the distribution of HLA class II (DRB1 and DQB1) alleles, their association with chronic HCV infection and their response to interferon therapy. One hundred and two unrelated white Brazilian patients with chronic HCV infection, 52 responders (45 males and 7 females) and 50 non-responders (43 males and 7 females) to antiviral treatment, were included in the study. Healthy Brazilian bone marrow donors of Caucasian origin from the same geographic area constituted the control group (HLA-DRB1, N = 99 and HLA-DQB1, N = 222 individuals). HLA class II genotyping was performed using a low-resolution DRB1, DQB1 sequence-specific primer amplification. There were higher frequencies of HLA-DRB1*13 (26.5 vs 14.1%) and HLA-DQB1*02 (52.9 vs 38.7%) in patients compared with controls; however, these were not significantly different after P correction (Pc = 0.39 and Pc = 0.082, respectively). There was no significant difference between the phenotypic frequencies of HLA-DRB1 (17.3 vs 14.0%) and HLA-DQB1 alleles in responder and non-responder HCV patients. The HLA-DRB1*07 allele was significantly more common in HCV patients (33.3 vs 12.1%) than in controls (Pc = 0.0039), suggesting that the HLA-DRB1*07 allele is associated with chronic HCV infection.

References Powered by Scopus

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

6000Citations
N/AReaders
Get full text

Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial

5976Citations
N/AReaders
Get full text

An algorithm for the grading of activity in chronic hepatitis C

3710Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Human Leukocyte Antigen (HLA) and immune regulation: How do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?

146Citations
N/AReaders
Get full text

Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance

29Citations
N/AReaders
Get full text

HLA class II alleles and chronic hepatitis C virus infection

22Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Corghi, D. B., Gonçales, N. S. L., Marques, S. B. D., & Gonçales, F. L. (2008). Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection. Brazilian Journal of Medical and Biological Research, 41(10), 884–889. https://doi.org/10.1590/S0100-879X2008005000041

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

50%

Professor / Associate Prof. 2

25%

Researcher 2

25%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 3

38%

Medicine and Dentistry 3

38%

Social Sciences 1

13%

Engineering 1

13%

Save time finding and organizing research with Mendeley

Sign up for free